Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 1
2002 2
2003 2
2004 2
2015 2
2017 2
2018 2
2019 2
2020 3
2021 5
2022 4
2023 1
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.
Mahé I, Carrier M, Mayeur D, Chidiac J, Vicaut E, Falvo N, Sanchez O, Grange C, Monreal M, López-Núñez JJ, Otero-Candelera R, Le Gal G, Yeo E, Righini M, Robert-Ebadi H, Huisman MV, Klok FA, Westerweel P, Agnelli G, Becattini C, Bamias A, Syrigos K, Szmit S, Torbicki A, Verhamme P, Maraveyas A, Cohen AT, Ay C, Chapelle C, Meyer G, Couturaud F, Mismetti P, Girard P, Bertoletti L, Laporte S; API-CAT Investigators. Mahé I, et al. N Engl J Med. 2025 Apr 10;392(14):1363-1373. doi: 10.1056/NEJMoa2416112. Epub 2025 Mar 29. N Engl J Med. 2025. PMID: 40162636 Clinical Trial.
[Early palliative care in oncology].
Bouleuc C, Burnod A, Angellier E, Massiani MA, Robin ML, Copel L, Chvetzoff G, Frasie V, Fogliarini A, Vinant P. Bouleuc C, et al. Among authors: massiani ma. Bull Cancer. 2019 Sep;106(9):796-804. doi: 10.1016/j.bulcan.2019.04.006. Epub 2019 Jun 4. Bull Cancer. 2019. PMID: 31174856 Review. French.
Accelerated subsequent lung cancer after post-operative radiotherapy for breast cancer.
Basse C, Ancel J, Massiani MA, Bonté PE, Beaulaton C, Beaucaire-Danel S, Milder M, Cao K, Daniel C, Du Rusquec P, Sablin MP, Kirova Y, Sage E, Beddok A, Girard N. Basse C, et al. Among authors: massiani ma. Lung Cancer. 2023 Aug;182:107295. doi: 10.1016/j.lungcan.2023.107295. Epub 2023 Jul 11. Lung Cancer. 2023. PMID: 37442059
Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO).
Wislez M, Mazieres J, Lavole A, Zalcman G, Carre O, Egenod T, Caliandro R, Dubos-Arvis C, Jeannin G, Molinier O, Massiani MA, Langlais A, Morin F, Le Pimpec Barthes F, Brouchet L, Assouad J, Milleron B, Damotte D, Antoine M, Westeel V. Wislez M, et al. Among authors: massiani ma. J Immunother Cancer. 2022 Oct;10(10):e005636. doi: 10.1136/jitc-2022-005636. J Immunother Cancer. 2022. PMID: 36270733 Free PMC article.
Paclitaxel-bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study.
Bilger G, Toffart AC, Darrason M, Duruisseaux M, Ulmer L, Wang P, Leprieur EG, Girard N, Massiani MA, Bore P, Descourt R, Pinsolle J, Valery S, Monnet I, Swalduz A, Tissot C, Fournel P, Baranzelli A, Cortot AB, Decroisette C. Bilger G, et al. Among authors: massiani ma. Ther Adv Med Oncol. 2022 Jun 6;14:17588359221099399. doi: 10.1177/17588359221099399. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35694190 Free PMC article.
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients.
Basse C, Diakite S, Servois V, Frelaut M, Noret A, Bellesoeur A, Moreau P, Massiani MA, Bouyer AS, Vuagnat P, Malak S, Bidard FC, Vanjak D, Kriegel I, Burnod A, Bilger G, Ramtohul T, Dhonneur G, Bouleuc C, Cassoux N; Institut Curie COVID Group,; Paoletti X, Bozec L, Cottu P. Basse C, et al. Among authors: massiani ma. JNCI Cancer Spectr. 2021 Jan 6;5(1):pkaa090. doi: 10.1093/jncics/pkaa090. eCollection 2021 Feb. JNCI Cancer Spectr. 2021. PMID: 33604509 Free PMC article.
Discontinuation of immune checkpoint inhibitor (ICI) above 18 months of treatment in real-life patients with advanced non-small cell lung cancer (NSCLC): INTEPI, a multicentric retrospective study.
Bilger G, Girard N, Doubre H, Levra MG, Giroux-Leprieur E, Giraud F, Decroisette C, Carton M, Massiani MA. Bilger G, et al. Among authors: massiani ma. Cancer Immunol Immunother. 2022 Jul;71(7):1719-1731. doi: 10.1007/s00262-021-03114-z. Epub 2021 Nov 25. Cancer Immunol Immunother. 2022. PMID: 34821950 Free PMC article. Clinical Trial.
Lung cancer in renal transplant recipients: A case-control study.
Rousseau-Gazaniol C, Fraboulet S, Couderc LJ, Kreis H, Borie R, Tricot L, Anglicheau D, Martinez F, Doubre H, Bonnette P, Mellot F, Massiani MA, Pelle G, Sage E, Moisson P, Delahousse M, Zemoura L, Chapelier A, Hamid AM, Puyo P, Longchampt E, Legendre C, Friard S, Catherinot E. Rousseau-Gazaniol C, et al. Among authors: massiani ma. Lung Cancer. 2017 Sep;111:96-100. doi: 10.1016/j.lungcan.2017.07.011. Epub 2017 Jul 11. Lung Cancer. 2017. PMID: 28838407
Efficacy and Safety of Combined Brain Stereotactic Radiotherapy and Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with Brain Metastases.
Porte J, Saint-Martin C, Frederic-Moreau T, Massiani MA, Bozec L, Cao K, Verrelle P, Otz J, Jadaud E, Minsat M, Langer A, Girard N, Créhange G, Beddok A. Porte J, et al. Among authors: massiani ma. Biomedicines. 2022 Sep 10;10(9):2249. doi: 10.3390/biomedicines10092249. Biomedicines. 2022. PMID: 36140349 Free PMC article.
32 results